Skip to content

Clinical trials

Triple Negative Breast Neoplasms trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Triple Negative Breast Neoplasms Status: Unknown status Clear all

129 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20115
20122
20133
20141
201510
20163
20179
201811
201918
202018
202113
202212
202316
20246

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status129

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fudan University20
Chinese Academy of Medical Sciences8
The First Affiliated Hospital with Nanjing Medical University3
Tianjin Medical University Cancer Institute and Hospital3
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.2
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano2
Infinity Pharmaceuticals, Inc.2
Istituti Ospitalieri di Cremona2
Ministry of Health, Saudi Arabia2
Northwestern University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Triple Negative Breast Neoplasms129
Breast Neoplasms45
Carcinoma, Non-Small-Cell Lung8
Ovarian Neoplasms7
Stomach Neoplasms7
Endometrial Neoplasms6
Carcinoma, Renal Cell4
Colorectal Neoplasms4
Melanoma4
Sarcoma4

Trials

Showing 1 to 25 of 129. Each trial links to its page on Pharma Observatory.

29 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.